At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,100 enrolled
Drug / intervention
Oxybutynindrug
Likely dose
Oxybutynin 10mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Retrospective Evaluation of Long Term Use of Oxybutynin in the Pharmacological Treatment of Primary Hyperhidrosis
In Brief
An observational study evaluating Oxybutynin for Hyperhidrosis. Completed, enrolled 1,100 participants across 1 site.
Detailed Summary
Evaluate the long term efficacy and side effects of oxybutynin in the treatment of hyperhidrosis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHyperhidrosis
CountriesBrazil
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2007
Primary CompletionSep 2013
First PostedOct 2013
TodayJul 2026
First PostedOct 8, 2013
Enrollment StartSep 1, 2007
Primary CompletionSep 1, 2013
TodayJul 2, 2026
Enrollment to primary: 6 yearsPosted 12.7 years ago
Interventions
Oxybutynindrug
All patients are treated with oxybutynin for hyperhidrosis. Usual maintenance dose is 10mg/day, but dose may vary according to weight, efficacy and side effects. Our standard protocol starts with 2.5mg/day in the first 7 days, progresses to 5mg/day for 14 days and then reaches the usual maintenance dose of 10mg/day afterwards.